Gufic Biosciences Ltd - 509079 - Announcement under Regulation 30 (LODR)-Cessation
Pursuant to Regulation 30 and other applicable provisions of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 and in continuance to our letter dated 13th August, 2019, we inform you that upon completion of the term as an Independent Director, Mr. Jagdish D. Shah (DIN: 06672538) ceased to be the Independent Director of the Company with effect from September 25, 2019. GUFIC BIOSCIENCES LTD. - 509079 - Fixes Book Closure for Dividend & AGM
Gufic Biosciences Ltd has informed BSE that the Register of Members & Share Transfer Books of the Company will remain closed from September 24, 2019 to September 30, 2019 (both days inclusive) for the purpose of Payment of Dividend & 35th Annual General Meeting (AGM) of the Company to be held on September 30, 2019. Gufic Biosciences Ltd - 509079 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Pursuant to Regulation 47 read with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed herewith the cutting of newspaper in which notice of the 35th Annual General Meeting (AGM) of the Company, Book Closure, E-voting and confirmation of dispatch of Annual Report were published. The said information were published in Business Standard (English Edition) and Mumbai Lakshadeep (Marathi Edition). Kindly take the same on record GUFIC BIOSCIENCES LTD. - 509079 - Reg. 34 (1) Annual Report
Please refer to our letter dated 6th September, 2019 vide reference no. 185/LG/SE/SEP/2019/GBSL, whereby the Company had made submission under Regulation 34(1) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('SEBI-LODR') of the Annual Report 2018-19 including the Independent Audit Report therein. Kindly be informed that through oversight and inadvertence, the Independent Auditor Report issued by the Statutory Auditors of the Company, stated in the said Annual Report submitted with the Stock Exchanges is of financial year 2017-18 instead of 2018-19. We hereby confirm that the error caused is purely unintentional on the part of the Company You are requested to consider the same and update the Revised Annual Report 2018-19 in your records. Kindly take the same on record. Gufic Biosciences Ltd - 509079 - Reg. 34 (1) Annual Report
Enclosed is the Annual Report 2018-19 Gufic Biosciences Ltd - 509079 - Shareholder Meeting-AGM On September 30, 2019
Pursuant to the provisions of Regulations 30 and 42 and other applicable provisions of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that the 35th Annual General Meeting of the Company is scheduled to be held at VITS - Luxury Business Hotels, Andheri Kurla Road, International Airport Zone, Andheri (East), Mumbai 400 059 on Monday, 30th September 2019 at 2.30 p.m. (IST). This is to further inform you that the Register of Members and the Share Transfer Books will remain closed from Tuesday, September 24, 2019 to Monday, September 30, 2019 (both days inclusive) for the purpose of AGM and determining the persons entitled for dividend for the year ended March 31, 2019. GUFIC BIOSCIENCES LTD. - 509079 - Shareholder Meeting-AGM On September 30, 2019
Pursuant to the provisions of Regulations 30 and 42 and other applicable provisions of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that the 35th Annual General Meeting of the Company is scheduled to be held at VITS - Luxury Business Hotels, Andheri Kurla Road, International Airport Zone, Andheri (East), Mumbai 400 059 on Monday, 30th September 2019 at 2.30 p.m. (IST). This is to further inform you that the Register of Members and the Share Transfer Books will remain closed from Tuesday, September 24, 2019 to Monday, September 30, 2019 (both days inclusive) for the purpose of AGM and determining the persons entitled for dividend for the year ended March 31, 2019. GUFIC BIOSCIENCES LTD. - 509079 - Outcome of Board Meeting
The Board of Directors of the Company at its Meeting held on August 20, 2019, which commenced at 3.00 p.m and concluded at 4.30 p.m, inter alia considered and approved the following: 1. Recommended Dividend @ 5% i.e Re. 0.05 per Equity share (Face Value of Re.1/- each) for the year ended March 31, 2019, subject to the approval of the Shareholders at the ensuing Annual General Meeting of the Company. GUFIC BIOSCIENCES LTD. - 509079 - Corporate Action-Board to consider Dividend
Pursuant to the provisions of Regulation 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended from time to time, we wish to inform you that the Meeting of the Board of Directors is scheduled to be held on Tuesday, August 20, 2019, inter alia to consider recommendation of Final Dividend for the financial year 2018-19. Gufic Biosciences Ltd - 509079 - Announcement under Regulation 30 (LODR)-Change in Directorate
The Board of Directors on the recommendation of the Nomination and Remuneration have subject to the approval of shareholders at the ensuing 35th Annual General Meeting approved:- a)Re-appointment of Mr. Jayesh Pannalal Choksi as a Chairman and Managing Director for a period of 5 (Five) years commencing from 01st April 2020 to 31st March 2025 (both days inclusive). b)Re-appointment of Mr. Pranav Jayesh Choksi as a Whole Time Director of the Company for a period of 5 (Five) years commencing from 01st April 2020 to 31st March 2025 (both days inclusive). c)Re-appointment of Mr. Shreyas K. Patel (DIN: 01638788) as an Independent Director of the Company for a term of 5 (Five) consecutive years w.e.f 26th September 2019 to 25th September 2024 (both days inclusive). d)Re-appointment of Mr. Gopal M. Daptari (DIN: 07660662) as Non-Executive Independent Director of the Company for a term of 5 (Five) consecutive years w.e.f 24th November 2019 to 23rd November 2024 (both days inclusive).